Search

everythinglearnresearchcommunity

for

Search:↓

Most people with alopecia areata have nail changes, which are common but don't greatly affect their quality of life.

People with alopecia areata have higher levels of a heart disease marker than those without hair loss.

Mechlorethamine treatment regrew hair in mice by killing immune cells causing hair loss without harming hair follicles.

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.

Severe pediatric alopecia areata worsens quality of life for patients and families.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

The monkey's hair loss was due to an autoimmune disease, not genetics.

Alopecia areata has a complex genetic basis that was not fully understood as of 2001.

The erbium-glass laser effectively promotes hair regrowth in alopecia areata.

ULBP3 could be a marker for diagnosing alopecia areata incognita and may be linked to its cause and development.

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

Combining light therapy, acid, and microneedling improves hair regrowth in stubborn hair loss cases.

Trichotillomania is often misdiagnosed as alopecia areata and can be treated effectively with N-acetylcysteine and psychotropic drugs.

Patients with severe alopecia areata have higher levels of MIF, which decrease after successful treatment.

Alopecia areata may be linked to imbalanced gut bacteria.

Cyclosporine combined with corticosteroids is more effective for severe alopecia areata than cyclosporine alone.

The laser comb did not improve hair regrowth in mice with alopecia areata.

Diphencyprone is effective for treating patchy hair loss in alopecia areata, but tacrolimus is not.

JAK inhibitors effectively improve hair regrowth in alopecia areata with an acceptable safety profile.

Topical diphencyprone helped regrow hair in mice and rats with a condition similar to human hair loss.

Allergies and atopic conditions may increase the risk of developing alopecia areata.

People with alopecia areata have higher rates of mental health issues, autoimmune diseases, and infections.

People with alopecia areata may be more likely to have a certain type of hearing loss.

Researchers developed an algorithm for self-diagnosing scalp conditions with high accuracy using smart device-attached microscopes.

The conclusion is that in the Indian subcontinent, socioeconomic status, stress, and family structure affect the severity of alopecia areata, and its psychological impact is generally mild or moderate.

Rare changes in the KRT82 gene are linked to a higher risk of Alopecia Areata.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

Fractional laser treatment helped hair regrowth in patients with alopecia areata.

Local corticosteroids can help with alopecia areata, but hair loss often returns after stopping treatment.